Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001)
- PMID: 12780837
- DOI: 10.1046/j.1464-410x.2003.04239.x
Catheter-associated urinary tract infections: prevalence of uropathogens and pattern of antimicrobial resistance in a UK hospital (1996-2001)
Abstract
Objective: To assess the change in the bacterial profile and pattern of antibiotic resistance of catheter-associated urinary tract infections (CAUTIs, the most prevalent form of nosocomial infections) between 1996 and 2001.
Materials and methods: Catheter samples of urine (CSUs) submitted in 1996, 1998 and 2001 (2451, 2460 and 3349 specimens, respectively) were analysed. The distribution of different uropathogens in bacterial CAUTIs and their in vitro antimicrobial resistance was evaluated over the study interval. The likelihood ratio test was used to assess whether there was a linear trend according to calendar year.
Results: Escherichia coli was the most frequently isolated pathogen in all years, but its frequency declined over time (35.6%, 32.5% and 26.6%, respectively). Enterococcus was the second most frequent overall, with a significant increase in frequency with time (11.8%, 15.3% and 22.0%, respectively). There was also a considerable change in resistance patterns to antibiotics. As a result, in 1996, CAUTIs were least often resistant to ciprofloxacin (8.0%) followed by co-amoxiclav (18.5%) and cephalexin (25.4%). In 2001, CAUTIs were least often resistant to co-amoxiclav (22.5%), followed by ciprofloxacin (27.2%) and nitrofurantoin (28.8%).
Conclusion: The types of organisms associated with CAUTI have changed over the last 5 years in a UK institution, as have the patterns of antibiotic resistance. Currently, the most appropriate agents for the empirical management of CAUTIs seem to be co-amoxiclav, ciprofloxacin and nitrofurantoin.
Similar articles
-
Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: results based on a retrospective study from a tertiary hospital.Am J Infect Control. 2013 Jul;41(7):601-6. doi: 10.1016/j.ajic.2012.09.015. Epub 2013 Jan 23. Am J Infect Control. 2013. PMID: 23352074
-
Species and antimicrobial resistance of uropathogens isolated from patients with urinary catheter.Tohoku J Exp Med. 2008 Apr;214(4):311-9. doi: 10.1620/tjem.214.311. Tohoku J Exp Med. 2008. PMID: 18441506
-
[Healthcare-associated urinary tract infections in patients with a urinary catheter: Risk factors, microbiological characteristics and patterns of antibiotic resistance].Arch Esp Urol. 2015 Jul-Aug;68(6):541-50. Arch Esp Urol. 2015. PMID: 26179791 Spanish.
-
[Urinary tract infections].Nihon Rinsho. 2002 Nov;60(11):2200-3. Nihon Rinsho. 2002. PMID: 12440130 Review. Japanese.
-
Catheter-associated urinary tract infection: an overview.J Basic Clin Physiol Pharmacol. 2022 Aug 29;34(1):5-10. doi: 10.1515/jbcpp-2022-0152. eCollection 2023 Jan 1. J Basic Clin Physiol Pharmacol. 2022. PMID: 36036578 Review.
Cited by
-
Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?Crit Care Med. 2008 Mar;36(3):1003-4. doi: 10.1097/CCM.0B013E318165FD78. Crit Care Med. 2008. PMID: 18431302 Free PMC article. No abstract available.
-
A review of the recent advances in antimicrobial coatings for urinary catheters.Acta Biomater. 2017 Mar 1;50:20-40. doi: 10.1016/j.actbio.2016.11.070. Epub 2016 Dec 1. Acta Biomater. 2017. PMID: 27916738 Free PMC article. Review.
-
Relevance of iron metabolic genes in biofilm and infection in uropathogenic Proteus mirabilis.Curr Res Microb Sci. 2021 Aug 17;2:100060. doi: 10.1016/j.crmicr.2021.100060. eCollection 2021 Dec. Curr Res Microb Sci. 2021. PMID: 34841350 Free PMC article.
-
CAUTI's next top model - Model dependent Klebsiella biofilm inhibition by bacteriophages and antimicrobials.Biofilm. 2020 Dec;2:100038. doi: 10.1016/j.bioflm.2020.100038. Biofilm. 2020. PMID: 33381752 Free PMC article.
-
Natural Cyanobacterial Polymer-Based Coating as a Preventive Strategy to Avoid Catheter-Associated Urinary Tract Infections.Mar Drugs. 2020 May 26;18(6):279. doi: 10.3390/md18060279. Mar Drugs. 2020. PMID: 32466349 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials